TuHURA Biosciences announces $12.5M private placement

TuHURA Biosciences (HURA) announced that it has entered into a definitive securities purchase agreement for the issuance and sale in a private placement of an aggregate of $12.5M of shares of its common stock, for an aggregate of 4.6M shares, together with warrants to purchase an equal number shares of common stock at an exercise price of $3.3125 per warrant share. The securities in the offering were sold at a combined purchase price of $2.65 per share and accompanying warrant, which represents a 15% discount to the NASDAQ closing price of the company’s common stock on June 2. The company currently anticipates that all of the Funding Milestones will be achieved by the end of July 2025. Paulson Investment Company acted as exclusive placement agent for the offering, and Brookline Capital Markets, a division of Arcadia Securities, provided equity market advisory services.